NCBI PubMed Central
open access
Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Related documents
- 10E8.4/iMab Bispecific Antibody in HIV-uninfected and HIV-infected Adults#394599
- A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC#913399
- Bispecific antibodies in gastrointestinal cancers: current applications and future perspectives.#1080696
- Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicity.#221031
- AZD8186 First Time In Patient Ascending Dose Study#840433
Record · ID 25594 · SHA-256 84fbdf21b44d8f94
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive